Cartesian Therapeutics
RNAC
RNAC
54 hedge funds and large institutions have $28M invested in Cartesian Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-11
Holders Change %
-16.92%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
26
Reduced
16
Closed
16
Calls
$1K
Puts
$10K
Net Calls
-$9K
Net Calls Change
-$1.45M
Top Buyers
| 1 |
Man Group
London,
United Kingdom
|
+$737K |
| 2 |
FI
Fosun International
Hong Kong,
China
|
+$531K |
| 3 |
JPMorgan Chase & Co
New York
|
+$339K |
| 4 |
Renaissance Technologies
New York
|
+$263K |
| 5 |
Two Sigma Investments
New York
|
+$249K |
Top Sellers
| 1 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.22M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.01M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$933K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$905K |
